{"id":8820,"date":"2015-08-06T14:59:05","date_gmt":"2015-08-06T13:59:05","guid":{"rendered":"http:\/\/kapitalis.com\/tunisie\/?p=8820"},"modified":"2015-08-06T14:59:05","modified_gmt":"2015-08-06T13:59:05","slug":"gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c","status":"publish","type":"post","link":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/","title":{"rendered":"Gilead accorde \u00e0 la Tunisie la licence du traitement  de l\u2019h\u00e9patite C"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-8821\" src=\"http:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2015\/08\/Gilead-hepatire-C.jpg\" alt=\"Gilead-hepatire-C\" width=\"626\" height=\"380\" \/><\/p>\n<p><em><strong>Gilead \u00e9largit l&rsquo;acc\u00e8s au traitement de l&rsquo;h\u00e9patite C chronique et accorde la Tunisie\u00a0 la licence du traitement.<\/strong><\/em><\/p>\n<p><!--more--><\/p>\n<p>L\u2019Association tunisienne de lutte contre les MST et le sida (ATL-Tunis) annonce, dans un communiqu\u00e9 publi\u00e9 jeudi, avoir appris, par un mail re\u00e7u le 3 ao\u00fbt, que le laboratoire pharmaceutique am\u00e9ricain Gilead a rajout\u00e9 la Tunisie \u00e0 la liste des pays qui auront acc\u00e8s \u00e0 l\u2019accord de licence des g\u00e9n\u00e9riques du traitement de l&rsquo;h\u00e9patite C chronique.<\/p>\n<p>Cette bonne nouvelle doit pousser les autorit\u00e9s tunisiennes \u00e0 \u00eatre r\u00e9actives aux demandes et aux besoins\u00a0 des personnes atteintes par cette maladie.<\/p>\n<p>ATL-Tunis signale \u00e9galement que, depuis l\u2019enregistrement du traitement aux \u00e9tats Unies et suite aux recommandations de l\u2019OMS pour son usage, elle n\u2019a pas cess\u00e9 de mener des actions de plaidoyer aux niveaux r\u00e9gional et international avec l\u2019appui et le soutien de la Coalition internationale pour la pr\u00e9paration au traitement dans la r\u00e9gion Afrique du Nord et Moyen Orient (ITPC-Mena), et de faire pression sur le laboratoire en question afin qu\u2019il l\u00e8ve l\u2019embargo sur les pays en d\u00e9veloppement.<\/p>\n<p>L\u2019association annonce, par ailleurs, la poursuite du combat pour une strat\u00e9gie nationale qui prenne en compte \u00e0 la fois la pr\u00e9vention bas\u00e9e sur l\u2019acc\u00e8s gratuit au test rapide de l\u2019h\u00e9patite C et l\u2019acc\u00e8s universel au traitement.<\/p>\n<p style=\"text-align: right;\"><strong>I. B.<\/strong> (avec Tap).<\/p>\n<p><em><strong>Article li\u00e9:<\/strong><\/em><\/p>\n<p><a href=\"http:\/\/kapitalis.com\/tunisie\/2015\/07\/28\/hepatites-gilead-et-bms-doivent-penser-aux-malades-de-tunisie-et-du-maroc\/\" target=\"_blank\"><em>H\u00e9patites: Gilead et BMS doivent penser aux malades de Tunisie et du Maroc<\/em><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gilead \u00e9largit l&rsquo;acc\u00e8s au traitement de l&rsquo;h\u00e9patite C chronique et accorde la Tunisie\u00a0 la licence du traitement.<\/p>\n","protected":false},"author":5,"featured_media":8821,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[998,2433],"tags":[2811,1846,913],"class_list":["post-8820","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-societe","category-tunisie","tag-generiques","tag-licence","tag-traitement"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Gilead accorde \u00e0 la Tunisie la licence du traitement de l\u2019h\u00e9patite C - Kapitalis<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead accorde \u00e0 la Tunisie la licence du traitement de l\u2019h\u00e9patite C - Kapitalis\" \/>\n<meta property=\"og:description\" content=\"Gilead \u00e9largit l&rsquo;acc\u00e8s au traitement de l&rsquo;h\u00e9patite C chronique et accorde la Tunisie\u00a0 la licence du traitement.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/\" \/>\n<meta property=\"og:site_name\" content=\"Kapitalis\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/KapitalisInfo\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-08-06T13:59:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/kapitalis-logo-fb.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ridha Elkefi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KapitalisInfo\" \/>\n<meta name=\"twitter:site\" content=\"@KapitalisInfo\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ridha Elkefi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/\"},\"author\":{\"name\":\"Ridha Elkefi\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/16627fc9b2fc0116230e88af071eebab\"},\"headline\":\"Gilead accorde \u00e0 la Tunisie la licence du traitement de l\u2019h\u00e9patite C\",\"datePublished\":\"2015-08-06T13:59:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/\"},\"wordCount\":270,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#organization\"},\"image\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"g\u00e9n\u00e9riques\",\"licence\",\"traitement\"],\"articleSection\":[\"SOCIETE\",\"Tunisie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/\",\"name\":\"Gilead accorde \u00e0 la Tunisie la licence du traitement de l\u2019h\u00e9patite C - Kapitalis\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-08-06T13:59:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/kapitalis.com\/tunisie\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead accorde \u00e0 la Tunisie la licence du traitement de l\u2019h\u00e9patite C\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#website\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/\",\"name\":\"Kapitalis\",\"description\":\"L&#039;actualit\u00e9 en Tunisie et dans le monde\",\"publisher\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kapitalis.com\/tunisie\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#organization\",\"name\":\"Kapitalis\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png\",\"contentUrl\":\"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png\",\"width\":5000,\"height\":1500,\"caption\":\"Kapitalis\"},\"image\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/KapitalisInfo\/\",\"https:\/\/x.com\/KapitalisInfo\",\"https:\/\/www.youtube.com\/channel\/UC-yDYrHyfFBWWZaOw3FPg9Q\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/16627fc9b2fc0116230e88af071eebab\",\"name\":\"Ridha Elkefi\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/author\/ridha-kefi\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gilead accorde \u00e0 la Tunisie la licence du traitement de l\u2019h\u00e9patite C - Kapitalis","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/","og_locale":"fr_FR","og_type":"article","og_title":"Gilead accorde \u00e0 la Tunisie la licence du traitement de l\u2019h\u00e9patite C - Kapitalis","og_description":"Gilead \u00e9largit l&rsquo;acc\u00e8s au traitement de l&rsquo;h\u00e9patite C chronique et accorde la Tunisie\u00a0 la licence du traitement.","og_url":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/","og_site_name":"Kapitalis","article_publisher":"https:\/\/www.facebook.com\/KapitalisInfo\/","article_published_time":"2015-08-06T13:59:05+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/kapitalis-logo-fb.png","type":"image\/png"}],"author":"Ridha Elkefi","twitter_card":"summary_large_image","twitter_creator":"@KapitalisInfo","twitter_site":"@KapitalisInfo","twitter_misc":{"\u00c9crit par":"Ridha Elkefi","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#article","isPartOf":{"@id":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/"},"author":{"name":"Ridha Elkefi","@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/16627fc9b2fc0116230e88af071eebab"},"headline":"Gilead accorde \u00e0 la Tunisie la licence du traitement de l\u2019h\u00e9patite C","datePublished":"2015-08-06T13:59:05+00:00","mainEntityOfPage":{"@id":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/"},"wordCount":270,"commentCount":1,"publisher":{"@id":"https:\/\/kapitalis.com\/tunisie\/#organization"},"image":{"@id":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#primaryimage"},"thumbnailUrl":"","keywords":["g\u00e9n\u00e9riques","licence","traitement"],"articleSection":["SOCIETE","Tunisie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/","url":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/","name":"Gilead accorde \u00e0 la Tunisie la licence du traitement de l\u2019h\u00e9patite C - Kapitalis","isPartOf":{"@id":"https:\/\/kapitalis.com\/tunisie\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#primaryimage"},"image":{"@id":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-08-06T13:59:05+00:00","breadcrumb":{"@id":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/kapitalis.com\/tunisie\/2015\/08\/06\/gilead-accorde-a-la-tunisie-la-licence-du-traitement-de-lhepatite-c\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/kapitalis.com\/tunisie\/"},{"@type":"ListItem","position":2,"name":"Gilead accorde \u00e0 la Tunisie la licence du traitement de l\u2019h\u00e9patite C"}]},{"@type":"WebSite","@id":"https:\/\/kapitalis.com\/tunisie\/#website","url":"https:\/\/kapitalis.com\/tunisie\/","name":"Kapitalis","description":"L&#039;actualit\u00e9 en Tunisie et dans le monde","publisher":{"@id":"https:\/\/kapitalis.com\/tunisie\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kapitalis.com\/tunisie\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/kapitalis.com\/tunisie\/#organization","name":"Kapitalis","url":"https:\/\/kapitalis.com\/tunisie\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/","url":"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png","contentUrl":"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png","width":5000,"height":1500,"caption":"Kapitalis"},"image":{"@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/KapitalisInfo\/","https:\/\/x.com\/KapitalisInfo","https:\/\/www.youtube.com\/channel\/UC-yDYrHyfFBWWZaOw3FPg9Q"]},{"@type":"Person","@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/16627fc9b2fc0116230e88af071eebab","name":"Ridha Elkefi","url":"https:\/\/kapitalis.com\/tunisie\/author\/ridha-kefi\/"}]}},"_links":{"self":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/posts\/8820","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/comments?post=8820"}],"version-history":[{"count":0,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/posts\/8820\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/media\/8821"}],"wp:attachment":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/media?parent=8820"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/categories?post=8820"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/tags?post=8820"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}